Total Knee Athroplasty Neuropathic Pain: Difference between revisions

No edit summary
No edit summary
Line 21: Line 21:
Neuropathic pain can be assessed by various validated scoring systems, the most commonly used is the [[PainDETECT]], a helpful assessment tool in this patient group.
Neuropathic pain can be assessed by various validated scoring systems, the most commonly used is the [[PainDETECT]], a helpful assessment tool in this patient group.


Various guidelines exist for the assessment and treatment of neuropathic pain. These include offering a choice of
Various guidelines exist for the assessment and treatment of neuropathic pain. These include [[Neuropathic Pain Medication|Neuropathic pain medication]] , such as:


* Amitriptyline, duloxetine, gabapentin or pregabalin as initial treatment. See [[Neuropathic Pain Medication|Neuropathic pain medications]].  
* Amitriptyline, duloxetine, gabapentin or pregabalin as initial treatment.
* Capsaicin cream or topical lidocaine is an option for localised neuropathic pain or neuroma
* Capsaicin cream or topical lidocaine is an option for localised neuropathic pain or neuroma



Revision as of 07:47, 4 April 2024


Original Editor - Lucinda hampton

Top Contributors - Lucinda hampton  

UNDER CONSTRUCTION 3.4.2024 Introduction[edit | edit source]

Knee joint arthroplasty (KJA) procedures are regularly performed, however up to 1/5 of these replacements cause patients to have a degree of long-term pain or are not satisfied with their surgery.

Neuropathic pain rates post KJA reach their max at six to twelve weeks after surgery, and approximately 6% patients will go on to have long term neuropathic pain.

  • Post-surgical pain with a neuropathic component is likely to be greater than pure nociceptive pain, affecting QOL.
  • Neuropathic pain may stem from sensitisation of peripheral nociceptors many sources eg inflamed synovium, damaged subchondral bone, surgery trauma.
  • Patients with a pre existing neuropathic pain elsewhere have a greater potential for chronic nociceptor stimulation and central pain transmission.

Features[edit | edit source]

Neuropathic pain is distinguished by the following features: pain not relieved by rest and analgesia; diffuse and difficult to localise pain; pain that radiates towards or away from the knee; pain associated with feelings of pressure, numbness, sensitivity, burning, stinging, electric shocks or rigidity.

Assessing[edit | edit source]

Neuropathic pain can be assessed by various validated scoring systems, the most commonly used is the PainDETECT, a helpful assessment tool in this patient group.

Various guidelines exist for the assessment and treatment of neuropathic pain. These include Neuropathic pain medication , such as:

  • Amitriptyline, duloxetine, gabapentin or pregabalin as initial treatment.
  • Capsaicin cream or topical lidocaine is an option for localised neuropathic pain or neuroma

Sub Heading 3[edit | edit source]

Resources[edit | edit source]

  • bulleted list
  • x

or

  1. numbered list
  2. x

References[edit | edit source]